Pharmacodynamics of Low and Standard Doses of Ticagrelor in Patients with End Stage Renal Disease on Hemodialysis

Back

ESC Premium Access

Pharmacodynamics of Low and Standard Doses of Ticagrelor in Patients with End Stage Renal Disease on Hemodialysis

Session: Clinical studies on platelet inhibition

Topic: Thrombosis and platelets

Speaker: Professor W. Kim (Seoul, KR)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Weon Kim

Kyung Hee Medical Center, Seoul (Korea (Republic of))

0 follower

9 more presentations in this session

Incidence of colorectal cancer in new users and non-users of low-dose aspirin for primary prevention of cardiovascular or cerebrovascular disease in the United Kingdom

Speaker: Doctor L. Garcia Rodriguez (Madrid, ES)

Short versus prolonged dual antiplatelet therapy duration after bare-metal stent implantation: 2-month landmark analysis from the Credo-Kyoto registry cohort-2

Speaker: Doctor M. Natsuaki (Saga, JP)

Clinical implications of low-dose aspirin in vasospastic angina : the 3-year prognosis

Speaker: Doctor Y. Lee (Seoul, KR)

Validation of the DAPT score in the all comer PRODIGY trial

Speaker: Doctor R. Piccolo (Naples, IT)

Aspirin desensitization in patients with coronary artery disease: results of a multicenter registry

Speaker: Doctor R. Rossini (Cuneo, IT)

Access the full session

Clinical studies on platelet inhibition

Speakers: Professor W. Kim, Doctor L. Garcia Rodriguez, Doctor M. Natsuaki, Doctor Y. Lee, Doctor R. Piccolo...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources